Heron Therapeutics, Inc.HRTXNASDAQ
LOADING
|||
Switch Symbol:
Year-over-year earnings per share growth rate
| Period | Value |
|---|---|
| Q3 2025 | -400.00% |
| Q2 2025 | -216.28% |
| Q1 2025 | -28.03% |
| Q4 2024 | 175.39% |
| Q3 2024 | 47.69% |
| Q2 2024 | -189.95% |
| Q1 2024 | 70.73% |
| Q4 2023 | 58.00% |
| Q3 2023 | 51.43% |
| Q2 2023 | -29.63% |
| Q1 2023 | -17.39% |
| Q4 2022 | 39.47% |
| Q3 2022 | 30.91% |
| Q2 2022 | 12.70% |
| Q1 2022 | -16.67% |
| Q4 2021 | -5.88% |
| Q3 2021 | 17.74% |
| Q2 2021 | -6.90% |
| Q1 2021 | 14.71% |
| Q4 2020 | -6.25% |
| Q3 2020 | -4.92% |
| Q2 2020 | -7.02% |
| Q1 2020 | 12.31% |
| Q4 2019 | -54.76% |
| Q3 2019 | 33.33% |
| Q2 2019 | 21.25% |
| Q1 2019 | -26.98% |
| Q4 2018 | -28.57% |
| Q3 2018 | 9.26% |
| Q2 2018 | 33.33% |
| Q1 2018 | 16.49% |
| Q4 2017 | -25.97% |
| Q3 2017 | 3.75% |
| Q2 2017 | 20.00% |
| Q1 2017 | 18.03% |
| Q4 2016 | 1.61% |
| Q3 2016 | -5.98% |
| Q2 2016 | -27.17% |
| Q1 2016 | -5.75% |
| Q4 2015 | -38.10% |